Loading…
Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression
Errors in chromosome segregation during mitosis have been recognized as a hallmark of tumor cells since the late 1800s, resulting in the long-standing hypothesis that mitotic abnormalities drive tumorigenesis. Recent work has shown that mitotic defects can promote tumors, suppress them, or do neithe...
Saved in:
Published in: | Developmental cell 2016-12, Vol.39 (6), p.638-652 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3 |
---|---|
cites | cdi_FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3 |
container_end_page | 652 |
container_issue | 6 |
container_start_page | 638 |
container_title | Developmental cell |
container_volume | 39 |
creator | Funk, Laura C. Zasadil, Lauren M. Weaver, Beth A. |
description | Errors in chromosome segregation during mitosis have been recognized as a hallmark of tumor cells since the late 1800s, resulting in the long-standing hypothesis that mitotic abnormalities drive tumorigenesis. Recent work has shown that mitotic defects can promote tumors, suppress them, or do neither, depending on the rate of chromosome missegregation. Here we discuss the causes of chromosome missegregation, their effects on tumor initiation and progression, and the evidence that increasing the rate of chromosome missegregation may be an effective chemotherapeutic strategy.
Errors in chromosome segregation are a hallmark of tumor cells. Furthermore, how mitotic defects affect tumors depends on the rate of chromosome missegregation. Funk et al. discuss causes of chromosome missegregation, their effects on tumor initiation and progression, and whether increasing chromosome missegregation rates may be an effective chemotherapeutic strategy. |
doi_str_mv | 10.1016/j.devcel.2016.10.023 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5204306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1534580716307614</els_id><sourcerecordid>27997823</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3</originalsourceid><addsrcrecordid>eNp9kMlOwzAQhi0EolB4A4T8AimOE8cJByRUsVQqiwRcuFjpeAKuWrvYSaW-PS5lvXCxPcv_j-cj5Chlg5Slxcl0oHEJOBvwGMXUgPFsi-ylpSyTVIh0O75FlieiZLJH9kOYstiYlmyX9LisKlnybI88j83S2BdqLB2Obk_pjWlda4CObGM0zky7orXVdNQGOnQ24FuHFjDQxnn62M3jee_dPEqc_Wh86BYLjyHE-IDsNPUs4OHn3SdPlxePw-tkfHc1Gp6PExC8ahPZ4ARYBkLIqpQTyaHRUBQCeaOlLEAjVBnjsqgLBpMyrxvgORes4MiZgDrrk7ON76KbzFED2tbXM7XwZl77lXK1UX8r1ryqF7dUgrM8Y0U0yDcG4F0IHptvbcrUmrWaqg1rtWa9zkbWUXb8e-636Avuz8cwbr806FUAs8anjUdolXbm_wnv78CULg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Funk, Laura C. ; Zasadil, Lauren M. ; Weaver, Beth A.</creator><creatorcontrib>Funk, Laura C. ; Zasadil, Lauren M. ; Weaver, Beth A.</creatorcontrib><description>Errors in chromosome segregation during mitosis have been recognized as a hallmark of tumor cells since the late 1800s, resulting in the long-standing hypothesis that mitotic abnormalities drive tumorigenesis. Recent work has shown that mitotic defects can promote tumors, suppress them, or do neither, depending on the rate of chromosome missegregation. Here we discuss the causes of chromosome missegregation, their effects on tumor initiation and progression, and the evidence that increasing the rate of chromosome missegregation may be an effective chemotherapeutic strategy.
Errors in chromosome segregation are a hallmark of tumor cells. Furthermore, how mitotic defects affect tumors depends on the rate of chromosome missegregation. Funk et al. discuss causes of chromosome missegregation, their effects on tumor initiation and progression, and whether increasing chromosome missegregation rates may be an effective chemotherapeutic strategy.</description><identifier>ISSN: 1534-5807</identifier><identifier>EISSN: 1878-1551</identifier><identifier>DOI: 10.1016/j.devcel.2016.10.023</identifier><identifier>PMID: 27997823</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aneuploidy ; Animals ; Carcinogenesis - pathology ; Chromosomal Instability ; CIN ; Humans ; Mitosis ; mitotic checkpoint ; Models, Biological ; Neoplasms - drug therapy ; Neoplasms - genetics ; Neoplasms - pathology ; spindle assembly checkpoint ; Tumor Suppressor Protein p53 - metabolism</subject><ispartof>Developmental cell, 2016-12, Vol.39 (6), p.638-652</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3</citedby><cites>FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27997823$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Funk, Laura C.</creatorcontrib><creatorcontrib>Zasadil, Lauren M.</creatorcontrib><creatorcontrib>Weaver, Beth A.</creatorcontrib><title>Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression</title><title>Developmental cell</title><addtitle>Dev Cell</addtitle><description>Errors in chromosome segregation during mitosis have been recognized as a hallmark of tumor cells since the late 1800s, resulting in the long-standing hypothesis that mitotic abnormalities drive tumorigenesis. Recent work has shown that mitotic defects can promote tumors, suppress them, or do neither, depending on the rate of chromosome missegregation. Here we discuss the causes of chromosome missegregation, their effects on tumor initiation and progression, and the evidence that increasing the rate of chromosome missegregation may be an effective chemotherapeutic strategy.
Errors in chromosome segregation are a hallmark of tumor cells. Furthermore, how mitotic defects affect tumors depends on the rate of chromosome missegregation. Funk et al. discuss causes of chromosome missegregation, their effects on tumor initiation and progression, and whether increasing chromosome missegregation rates may be an effective chemotherapeutic strategy.</description><subject>Aneuploidy</subject><subject>Animals</subject><subject>Carcinogenesis - pathology</subject><subject>Chromosomal Instability</subject><subject>CIN</subject><subject>Humans</subject><subject>Mitosis</subject><subject>mitotic checkpoint</subject><subject>Models, Biological</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - pathology</subject><subject>spindle assembly checkpoint</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><issn>1534-5807</issn><issn>1878-1551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kMlOwzAQhi0EolB4A4T8AimOE8cJByRUsVQqiwRcuFjpeAKuWrvYSaW-PS5lvXCxPcv_j-cj5Chlg5Slxcl0oHEJOBvwGMXUgPFsi-ylpSyTVIh0O75FlieiZLJH9kOYstiYlmyX9LisKlnybI88j83S2BdqLB2Obk_pjWlda4CObGM0zky7orXVdNQGOnQ24FuHFjDQxnn62M3jee_dPEqc_Wh86BYLjyHE-IDsNPUs4OHn3SdPlxePw-tkfHc1Gp6PExC8ahPZ4ARYBkLIqpQTyaHRUBQCeaOlLEAjVBnjsqgLBpMyrxvgORes4MiZgDrrk7ON76KbzFED2tbXM7XwZl77lXK1UX8r1ryqF7dUgrM8Y0U0yDcG4F0IHptvbcrUmrWaqg1rtWa9zkbWUXb8e-636Avuz8cwbr806FUAs8anjUdolXbm_wnv78CULg</recordid><startdate>20161219</startdate><enddate>20161219</enddate><creator>Funk, Laura C.</creator><creator>Zasadil, Lauren M.</creator><creator>Weaver, Beth A.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20161219</creationdate><title>Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression</title><author>Funk, Laura C. ; Zasadil, Lauren M. ; Weaver, Beth A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aneuploidy</topic><topic>Animals</topic><topic>Carcinogenesis - pathology</topic><topic>Chromosomal Instability</topic><topic>CIN</topic><topic>Humans</topic><topic>Mitosis</topic><topic>mitotic checkpoint</topic><topic>Models, Biological</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - pathology</topic><topic>spindle assembly checkpoint</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Funk, Laura C.</creatorcontrib><creatorcontrib>Zasadil, Lauren M.</creatorcontrib><creatorcontrib>Weaver, Beth A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Developmental cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Funk, Laura C.</au><au>Zasadil, Lauren M.</au><au>Weaver, Beth A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression</atitle><jtitle>Developmental cell</jtitle><addtitle>Dev Cell</addtitle><date>2016-12-19</date><risdate>2016</risdate><volume>39</volume><issue>6</issue><spage>638</spage><epage>652</epage><pages>638-652</pages><issn>1534-5807</issn><eissn>1878-1551</eissn><abstract>Errors in chromosome segregation during mitosis have been recognized as a hallmark of tumor cells since the late 1800s, resulting in the long-standing hypothesis that mitotic abnormalities drive tumorigenesis. Recent work has shown that mitotic defects can promote tumors, suppress them, or do neither, depending on the rate of chromosome missegregation. Here we discuss the causes of chromosome missegregation, their effects on tumor initiation and progression, and the evidence that increasing the rate of chromosome missegregation may be an effective chemotherapeutic strategy.
Errors in chromosome segregation are a hallmark of tumor cells. Furthermore, how mitotic defects affect tumors depends on the rate of chromosome missegregation. Funk et al. discuss causes of chromosome missegregation, their effects on tumor initiation and progression, and whether increasing chromosome missegregation rates may be an effective chemotherapeutic strategy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27997823</pmid><doi>10.1016/j.devcel.2016.10.023</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1534-5807 |
ispartof | Developmental cell, 2016-12, Vol.39 (6), p.638-652 |
issn | 1534-5807 1878-1551 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5204306 |
source | BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS |
subjects | Aneuploidy Animals Carcinogenesis - pathology Chromosomal Instability CIN Humans Mitosis mitotic checkpoint Models, Biological Neoplasms - drug therapy Neoplasms - genetics Neoplasms - pathology spindle assembly checkpoint Tumor Suppressor Protein p53 - metabolism |
title | Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A48%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Living%20in%20CIN:%20Mitotic%20Infidelity%20and%20Its%20Consequences%20for%20Tumor%20Promotion%20and%20Suppression&rft.jtitle=Developmental%20cell&rft.au=Funk,%20Laura%20C.&rft.date=2016-12-19&rft.volume=39&rft.issue=6&rft.spage=638&rft.epage=652&rft.pages=638-652&rft.issn=1534-5807&rft.eissn=1878-1551&rft_id=info:doi/10.1016/j.devcel.2016.10.023&rft_dat=%3Cpubmed_cross%3E27997823%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/27997823&rfr_iscdi=true |